Stem Cell Therapy for Diabetes

The treatment of patients with diabetes mellitus may greatly benefit from the use of undifferentiated or undeveloped cells. The developmental stages and transcription factors involved in this process have been defined by research on the capacity of human embryonic undifferentiated cells to segregate into islet cells. In any event, ethical considerations as well as the possibility for teratoma formation limit the clinical applications of human embryonic stem cells.

 

  • Umbilical cord stem cells
  • Diabetes type 2
  • Bone marrow

Related Conference of Stem Cell Therapy for Diabetes

March 26-27, 2026

7th Global summit on Diabetes and Endocrinology

Amsterdam, Netherlands
May 14-15, 2026

7th World Summit on Diabetes

Rome, Italy
May 18-19, 2026

57th Annual Congress on Endocrinology and Diabetes Research

Aix-en-Provence, France
June 22-23, 2026

16th World Congress on Endocrinology and Diabetes

Paris, France
August 17-18, 2026

4th World congress and Expo on Diabetes

Toronto, Canada
September 29-30, 2026

22nd World Congress on Endocrinology & Diabetes

Paris, France

Stem Cell Therapy for Diabetes Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in